Price $177.24 |
Market Cap
448.33B
|
Sector Health Care |
Div. Growth
5.80%
|
|
P/E
23.9
|
P/B
6.04
|
P/S
4.69
|
Dividend %
2.60%
|
|
P/CF
-
|
P/FCF
73.5
|
Op. Cash Flow
21.58M
|
FCF
2.3
|
|
Op. Margin
23.30%
|
Net Margin
19.90%
|
ROE
25.60%
|
ROI
19.40%
|
|
ROA
10.70%
|
EPS Growth
7.80%
|
Current Ratio
1.3
|
Debt/Equity
40.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| RegeneRx Biopharmaceuticals In (RGRX) | $0.16 | - | - | 21.5M | Strong Buy |
| HTG Molecular Diagnostics Inc (HTGM) | $0.48 | - | - | 5.3M | Strong Buy |
| Helius Medical Technologies In (HSDT) | $0.34 | - | - | 7.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.41 | - | - | 105.8M | Strong Buy |
| Greenrose Holding Company Inc (GNRS) | $0.60 | - | - | 18.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
